Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net income including noncontrolling interests	$ 279,839	$ 256,988	$ 407,716
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	93,881	104,606	101,098
Impairment and other charges	16,699	122,227	106,603
Share-based compensation expenses related to equity classified awards	47,925	52,908	64,133
Non-cash restructuring and other related charges	4,329	5,359	14,098
Amortization and write-off of program rights	909,339	923,886	974,835
Amortization of deferred carriage fees	29,709	28,231	21,587
Unrealized foreign currency transaction (gain) loss	(16,882)	3,099	(16,325)
Amortization of deferred financing costs and discounts on indebtedness	7,729	8,005	8,007
Loss on extinguishment of debt	22,074	2,908	0
Bad debt (recoveries) expense	5,337	(2,843)	12,641
Deferred income taxes	34,010	23,159	(38,916)
Gains on investments	(1,306)	(97,617)	0
Write-down of non-marketable equity securities and note receivable	0	20,000	20,206
Other, net	(7,216)	(594)	(2,832)
Changes in assets and liabilities:
Accounts receivable, trade (including amounts due from related parties, net)	(56)	63,337	(43,345)
Prepaid expenses and other assets	(183,861)	64,060	(142,303)
Program rights and obligations, net	(1,297,782)	(850,013)	(969,900)
Income taxes payable	(3,467)	6,703	1,219
Deferred revenue	126,832	7,202	8,667
Deferred carriage fees, net	(53,065)	(8,833)	(15,033)
Accounts payable, accrued liabilities and other liabilities	129,406	15,958	(28,408)
Net cash provided by operating activities	143,474	748,736	483,748
Cash flows from investing activities:
Capital expenditures	(42,572)	(46,595)	(91,604)
Return of capital from investees	0	1,872	5,380
Acquisition of investments	(30,273)	(5,440)	(3,483)
Cash paid on distribution of business	(7,052)	0	0
Principal payments received on loans to investees	20,000	5,000	0
Payments for acquisitions of businesses, net of cash acquired	(62,055)	0	0
Proceeds from sale of investments	95,370	10,000	0
Net cash used in investing activities	(26,582)	(35,163)	(89,707)
Cash flows from financing activities:
Proceeds from the issuance of long-term debt	986,000	6,000	1,521
Principal payments on long-term debt	(1,016,500)	(262,250)	(22,988)
Deemed repurchase of restricted stock units	(32,886)	(15,967)	(23,018)
Purchase of treasury stock	0	(356,701)	(70,598)
Proceeds from stock option exercises	9,795	0	4,630
Principal payments on finance lease obligations	(3,800)	(3,261)	(5,115)
Contributions from noncontrolling interest	2,702	0	0
Distributions to noncontrolling interest	(29,414)	(15,819)	(15,558)
Net cash used in financing activities	(84,103)	(647,998)	(131,126)
Net increase in cash and cash equivalents from operations	32,789	65,575	262,915
Effect of exchange rate changes on cash and cash equivalents	(29,094)	6,781	(1,631)
Cash and cash equivalents at beginning of year	888,526	816,170	554,886
Cash and cash equivalents at end of year	$ 892,221	$ 888,526	$ 816,170